Oncology
Cyclophosphamide Tablets 50mg
Tablet — 50mg
WHO-GMP
US-FDA
Product Overview
Alkylating agent with broad antineoplastic activity. Used in various combination chemotherapy protocols.
Indications
Lymphomas, leukemias, solid tumors, autoimmune conditions
Dosage Forms & Strength
Available Forms
Tablet
Strength
50mg
Regulatory Approvals
WHO-GMP
US-FDA